Cost and Availability Access to medications like Mounjaro and Ozempic for weight management in India can be limited and expensive
A recent study published in Diabetes Obesity and Metabolism found that individuals using these medications lost significant amounts of fat but also experienced some degree of muscle loss, with lean body mass reductions making up approximately 25%40% of total weight Trusted Source Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies Neeland IJ, Linge J, Birkenfeld AL Go to Source loss
And yet
6 Compared with placebo, semaglutide has been shown to result in greater improvements in cardiometabolic risk factors such as waist circumference, blood pressure, lipid levels, and A1C levels
Within one year of stopping, they regained approximately two-thirds of the weight they had lost
Keep in mind, though, that this is based on results from rodent studies, so its still unclear whether these medications contribute to thyroid tumors in humans